Skip to Content
  • Previous Rank
  • Revenues ($M)
  • Revenue Percent Change
  • Profits ($M)
  • Profits Percent Change
  • Assets ($M)
  • Employees
  • Market Value — as of March 31, 2017 ($M)

AmerisourceBergen is the second-largest distributor of pharmaceuticals in the U.S. As such, it’s subject to many of the same forces affecting McKesson, its top competitor. Branded drug price deflation and fewer expected new drug launches continue to put pressure on industry profits, and AmerisourceBergen has been working to counter those effects. The company was founded in 1985 and is headquartered in Chesterbrook, Penn.

Created with sketchtool.Created with sketchtool.Looking for leads, investment insights, or competitive intelligence?Buy Now

Company Info

Steven H. Collis
CEO Title
Chairman, President & Chief Executive Officer
Wholesalers: Health Care
HQ Location
Chesterbrook, PA
Years on Fortune 500 List23
Figures are for fiscal year ended Sept. 30, 2016.

AmerisourceBergen Rank History


Key Financials (Last Fiscal Year)

$ millions% change
Revenues ($M)$146,8508%
Profits ($M)$1,427.9-
Assets ($M)$33,656-
Total Stockholder Equity ($M)$2,129-
Market Value — as of March 31, 2017 ($M)$19,229-

Profit Ratios

Profit as % of Revenues1%
Profits as % of Assets4.2%
Profits as % of Stockholder Equity67.1%

Earnings Per Share (Last Fiscal Year)

Earnings Per Share ($)6.32
EPS % Change (from 2015)-
EPS % Change (5 year annual rate)20%
EPS % Change (10 year annual rate)18.8%

Total Return

Total Return to Investors (2016)-23.3%
Total Return to Investors (5 year, annualized)17.7%
Total Return to Investors (10 year, annualized)15%